IMPORTANT NOTICE on COVID-19 Reporting at IndraStra Global
IndraStra Global

IMPORTANT NOTICE on COVID-19 Reporting at IndraStra Global

By IndraStra Global Editorial Team

IMPORTANT NOTICE on COVID-19 Reporting at IndraStra Global

From April 22, 2020, onwards we are restricting all opinion-based reporting or insights on COVID-19/Coronavirus at IndraStra Global owned/managed publishing platforms. This restriction will remain active until further notice.

For research articles/papers, we will be soon deploying a pre-print database at IndraStra Open Journal Systems, where one can deposit their non-typeset version of their work published before and/or after in a Journal or Conferences and Proceedings.

Kindly Note

Academicians, scientists, and policymakers must take quick steps and avoid missteps. Proper scientific method and conduct of studies, carefully reviewed publications, and cogent post-release interpretations are necessary safeguards that ensure the best and safest solutions are deployed at all the levels.

The pressure and desperation of the moment are forcing researchers and policymakers to be innovative and act quickly, but what is done should stay within the guiding concepts of academic research.

List of Qualified Organization to Share/Post COVID-19/CORONAVIRUS related information with IndraStra Global;

  1. World Health Organization
  2. U.S. Food and Drug Administration
  3. United Nations
  4. International Monetary Fund
  5. The World Bank
  6. Asian Development Bank
  7. African Development Bank
  8. European Bank for Reconstruction and Development  
  9. Associated Press
  10. Agence France-Presse
  11. Reuters
  12. S&P GLOBAL
  13. PR Newswire
  14. BusinessWire
  15. The Conversation (All Sites)
  16. Government-owned Press Bureaus
  17. Government-owned Think-tanks 

For more details, contact;

Rose McReid
Email: info@indrastra.com
Phone:+1-516-430-7789

IndraStra Global is now available on
Apple NewsGoogle News, Flipboard, Feedburner, and Telegram